Qin Cao

1.1k citations
27 papers · 698 indexed · h-index 14
Topics
Advanced Data Storage Technologies (3 papers)Inflammatory Bowel Disease (3 papers)Metabolomics and Mass Spectrometry Studies (2 papers)
Partner nations
ChinaUnited StatesChile

In The Last Decade

Qin Cao

23 papers receiving 686 citations

Peers

Qin Cao
Comparison fields: 5 of 108
  • Obstetrics and Gynecology 202
  • Oncology 168
  • Infectious Diseases 158
  • Surgery 100
  • Molecular Biology 94
Replace Masashi Yoshida with:
Masashi Yoshida Japan
Emmanuel Sampene United States
Marcelo Chen Taiwan
Bartosz Szostak Poland
Raffaele La Porta Italy
Carmine Sellitto Italy
Teklie Mengie Ayele Ethiopia
Gökhan Çakırca Türkiye
Sarah N. Campion United States
Paola Caruso Italy
Qin Cao relative to Masashi Yoshida Japan Masashi Yoshida's profile →
Citations per field
00.5×5.8×
Masashi Yoshida · 1×
Citations per year

Countries citing papers authored by Qin Cao

Since Specialization
Citations

This map shows the geographic impact of Qin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Cao more than expected).

Fields of papers citing papers by Qin Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Cao. The network helps show where Qin Cao may publish in the future.

Co-authorship network of co-authors of Qin Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Qin Cao. A scholar is included among the top collaborators of Qin Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Cao. Qin Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3
TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome.
20
4 1
5 298
6 1
7 19
8 16
9 0
10 30
11 26
12 13
13 43
14 4
15 5
16 22
17 4
18 3
19 13
20 13

About Qin Cao

Qin Cao is a scholar working on Filtration and Separation, Obstetrics and Gynecology and Cancer Research, having authored 27 papers that have together received 698 indexed citations. Recurring topics across this work include Advanced Data Storage Technologies (3 papers), Inflammatory Bowel Disease (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Obstetrics and Gynecology (202 citations), Infectious Diseases (158 citations) and Reproductive Medicine (54 citations). Qin Cao has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Cong Dai, Min Jiang, Xiang Li, Bo Huang, Lin Ma, Xiu Nie, Shuo Chen, Qiang Liu, Knarik Arkun and Jun He. Their work appears in journals such as Molecules, Experimental Cell Research and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026